Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

Pharmacokinetics of a Single Dose of Ceftaroline in Subjects 12 to 17 Years of Age Receiving Antibiotic Therapy

The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects

The purpose of this study is to determine the pharmacokinetics profile of ceftaroline in pediatric subjects

Inclusion Criteria:

• Hospitalized and receiving antibiotic therapy for treatment of a suspected infection of any type
• Body mass index (weight [kg]/height squared [m2]) of no more than 30
• Males and females between 12 and 17 years of age, inclusive

Exclusion Criteria:

• History of any hypersensitivity or allergic reaction to any β-lactam antimicrobial
• Past or current history of epilepsy or seizure disorder
• Critically ill or unstable patients